Management of NPO Status in Moderate to Severe DKA

Initial Management Phase

• Patients with moderate to severe DKA are typically unable to eat due to nausea and vomiting, altered mental status, abdominal pain, and Kussmaul respirations, but NPO status is not a mandated treatment requirement 2, 3

Transition to Oral Intake

• The American Diabetes Association recommends that patients with DKA should eat when able, rather than maintaining NPO status as standard practice, and transition to a multiple-dose insulin schedule using short/rapid-acting and intermediate/long-acting insulin once DKA is resolving 1

Management During NPO Period

• Patients who remain NPO should continue intravenous insulin infusion at 0.1 units/kg/hour until DKA resolution, regardless of glucose levels, and add dextrose-containing fluids when glucose falls below a certain level to prevent hypoglycemia 1, 2
• The target glucose level during NPO period should be between 150-200 mg/dL until DKA resolution parameters are met 1, 2
• Blood glucose should be monitored every 2-4 hours 2, 4

Critical Pitfalls to Avoid

• Never stop IV insulin just because the patient cannot eat, as this can lead to DKA recurrence 4
• Premature termination of insulin therapy before complete resolution of ketosis can lead to recurrent DKA 2
• Failure to add dextrose when glucose falls below a certain level while continuing insulin therapy can cause hypoglycemia 2